Related Experiment Videos
Hepatitis delta: the virus and the disease
1Institute of Internal Medicine, University of Turin, Italy.
Journal of Hepatology
|January 1, 1990
Summary
Hepatitis delta virus (HDV) RNA acts as a ribozyme, similar to plant viruses. New research suggests HDV can establish latent infections, with hepatitis B virus (HBV) reactivation being a third disease pathway.
Area of Science:
- Virology
- Molecular Biology
- Hepatology
Background:
- Hepatitis delta virus (HDV) shares biological and structural similarities with plant viroids and satellite RNA viruses.
- HDV RNA exhibits autocleavage and autoligation properties, characteristic of ribozymes, found in conserved domains homologous to viroids.
- The established pathobiology of delta hepatitis posits that HDV requires hepatitis B virus (HBV) for infection and is highly pathogenic.
Purpose of the Study:
- To investigate the role of HDV in latent infections and its interaction with HBV.
- To explore a potential third pathobiological mechanism for delta hepatitis development.
Main Methods:
- Analysis of biological and structural properties of HDV RNA.
- Investigation using a liver transplantation model to study HDV infection dynamics.
- Observation of disease reactivation upon HBV reintroduction in the liver graft.
Main Results:
- HDV RNA possesses catalytic properties, identifying it as the first mammalian ribozyme.
- Evidence suggests HDV can establish latent, asymptomatic infections independent of HBV.
- Disease reactivation in the liver transplantation model occurred only after HBV superinfection of a latent HDV state.
Conclusions:
- HDV RNA functions as a ribozyme, highlighting a link between plant and mammalian RNA viruses.
- HDV may establish latent infections without requiring HBV co-infection.
- HBV superinfection of a latent HDV infection represents a novel and significant pathobiological mechanism for delta hepatitis.